Logo image of ZBAO

ZHIBAO TECHNOLOGY INC (ZBAO) Stock Fundamental Analysis

NASDAQ:ZBAO - KYG989MC1063 - Common Stock

1.015 USD
-0.01 (-0.49%)
Last: 8/27/2025, 8:24:41 PM
1 USD
-0.01 (-1.48%)
After Hours: 8/27/2025, 8:24:41 PM
Fundamental Rating

4

Taking everything into account, ZBAO scores 4 out of 10 in our fundamental rating. ZBAO was compared to 143 industry peers in the Insurance industry. ZBAO scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ZBAO is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ZBAO was profitable.
ZBAO Yearly Net Income VS EBIT VS OCF VS FCFZBAO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

1.2 Ratios

ZBAO has a Return On Assets of 3.73%. This is in the better half of the industry: ZBAO outperforms 76.22% of its industry peers.
ZBAO has a better Return On Equity (15.95%) than 74.13% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.56%, ZBAO belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
Industry RankSector Rank
ROA 3.73%
ROE 15.95%
ROIC 7.56%
ROA(3y)-4.15%
ROA(5y)N/A
ROE(3y)-13.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ZBAO Yearly ROA, ROE, ROICZBAO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

ZBAO has a Profit Margin of 3.56%. This is in the lower half of the industry: ZBAO underperforms 66.43% of its industry peers.
ZBAO has a Operating Margin of 4.22%. This is in the lower half of the industry: ZBAO underperforms 76.92% of its industry peers.
ZBAO has a Gross Margin of 35.55%. This is amongst the best in the industry. ZBAO outperforms 90.91% of its industry peers.
In the last couple of years the Gross Margin of ZBAO has declined.
Industry RankSector Rank
OM 4.22%
PM (TTM) 3.56%
GM 35.55%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.48%
GM growth 5YN/A
ZBAO Yearly Profit, Operating, Gross MarginsZBAO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ZBAO is destroying value.
ZBAO has more shares outstanding than it did 1 year ago.
The debt/assets ratio for ZBAO has been reduced compared to a year ago.
ZBAO Yearly Shares OutstandingZBAO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M
ZBAO Yearly Total Debt VS Total AssetsZBAO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

ZBAO has an Altman-Z score of 1.42. This is a bad value and indicates that ZBAO is not financially healthy and even has some risk of bankruptcy.
ZBAO has a Altman-Z score of 1.42. This is amongst the best in the industry. ZBAO outperforms 85.31% of its industry peers.
ZBAO has a Debt/Equity ratio of 0.67. This is a neutral value indicating ZBAO is somewhat dependend on debt financing.
The Debt to Equity ratio of ZBAO (0.67) is worse than 82.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Altman-Z 1.42
ROIC/WACC0.86
WACC8.81%
ZBAO Yearly LT Debt VS Equity VS FCFZBAO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

ZBAO has a Current Ratio of 1.27. This is a normal value and indicates that ZBAO is financially healthy and should not expect problems in meeting its short term obligations.
ZBAO's Current ratio of 1.27 is amongst the best of the industry. ZBAO outperforms 82.52% of its industry peers.
A Quick Ratio of 1.27 indicates that ZBAO should not have too much problems paying its short term obligations.
ZBAO has a better Quick ratio (1.27) than 82.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.27
ZBAO Yearly Current Assets VS Current LiabilitesZBAO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

8

3. Growth

3.1 Past

ZBAO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.81%, which is quite impressive.
Looking at the last year, ZBAO shows a very strong growth in Revenue. The Revenue has grown by 45.81%.
Measured over the past years, ZBAO shows a very strong growth in Revenue. The Revenue has been growing by 59.09% on average per year.
EPS 1Y (TTM)119.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.21%
Revenue 1Y (TTM)45.81%
Revenue growth 3Y59.09%
Revenue growth 5YN/A
Sales Q2Q%73.73%

3.2 Future

ZBAO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 69.56% yearly.
The Revenue is expected to grow by 36.51% on average over the next years. This is a very strong growth
EPS Next Y57.5%
EPS Next 2Y69.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year38.78%
Revenue Next 2Y36.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ZBAO Yearly Revenue VS EstimatesZBAO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 100M 200M 300M 400M
ZBAO Yearly EPS VS EstimatesZBAO Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

ZBAO is valuated rather expensively with a Price/Earnings ratio of 20.30.
Based on the Price/Earnings ratio, ZBAO is valued a bit more expensive than 69.23% of the companies in the same industry.
ZBAO is valuated rather cheaply when we compare the Price/Earnings ratio to 27.14, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 6.19, the valuation of ZBAO can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ZBAO indicates a somewhat cheap valuation: ZBAO is cheaper than 76.92% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.80. ZBAO is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 20.3
Fwd PE 6.19
ZBAO Price Earnings VS Forward Price EarningsZBAO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ZBAO's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.99
ZBAO Per share dataZBAO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ZBAO's earnings are expected to grow with 69.56% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y69.56%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ZBAO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZHIBAO TECHNOLOGY INC

NASDAQ:ZBAO (8/27/2025, 8:24:41 PM)

After market: 1 -0.01 (-1.48%)

1.015

-0.01 (-0.49%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap32.53M
AnalystsN/A
Price TargetN/A
Short Float %0.25%
Short Ratio0.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20.3
Fwd PE 6.19
P/S 0.71
P/FCF N/A
P/OCF N/A
P/B 3.16
P/tB 3.25
EV/EBITDA 11.99
EPS(TTM)0.05
EY4.93%
EPS(NY)0.16
Fwd EY16.15%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.44
BVpS0.32
TBVpS0.31
PEG (NY)0.35
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.73%
ROE 15.95%
ROCE 17.23%
ROIC 7.56%
ROICexc 9.64%
ROICexgc 9.83%
OM 4.22%
PM (TTM) 3.56%
GM 35.55%
FCFM N/A
ROA(3y)-4.15%
ROA(5y)N/A
ROE(3y)-13.33%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.48%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.67
Debt/FCF N/A
Debt/EBITDA 2.87
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.27
Quick Ratio 1.27
Altman-Z 1.42
F-ScoreN/A
WACC8.81%
ROIC/WACC0.86
Cap/Depr(3y)25.8%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%85.21%
EPS Next Y57.5%
EPS Next 2Y69.56%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)45.81%
Revenue growth 3Y59.09%
Revenue growth 5YN/A
Sales Q2Q%73.73%
Revenue Next Year38.78%
Revenue Next 2Y36.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y126.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year695.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-50.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-238.94%
OCF growth 3YN/A
OCF growth 5YN/A